Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712704 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Breakdown of Prescriptions for Antidepressants by Diagnosis' returned 5 results - Page 1 of 1

  Sort by   
  Sorted by Rank Top-Bottom

Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market  
Datamonitor, Dec 2010, Pages: 198
and diagnosis rates, care pathway, and segmentation of depression cases by disease severity, age, and gender. - In-depth analysis of treatment patterns and regimens prescribed for MDD by antidepressant class


Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report  
Global Industry Analysts, Inc., Aug 2011, Pages: 433
-2009, New Drug Launches Likely to Affect Sales 9 Safety Concerns of Available Drugs and Low Rate of Diagnosis Limit Market Growth 9 Growth Drivers 10 IBS Market is Presently Highly Fragmented


Pediatric Drugs and Vaccines - Global Strategic Business Report  
Global Industry Analysts, Inc., April 2011, Pages: 1088
For several years, physicians were paralyzed with lack of information and options for prescribing treatment to patients in the pediatrics market. Many were compelled to rely on off-label prescription of drugs


The Global Diabetes Market: Therapeutics, Diagnostics and Complications  
Arrowhead Publishers, Aug 2006, Pages: 218
market breakdown of key products and players in the non-insulin, insulin, diagnostic and diabetic neuropathy areas - Individual chapters outlining the drivers of and resistors on this growing market - Clinical


Stakeholder Insight: Cancer Pain - Physician survey highlights inadequacies in education and treatment  
Datamonitor, Dec 2009, Pages: 247
Treatment options Pharmacological treatment options Non-steroidal anti-inflammatory drugs Opioids Antidepressants Anticonvulsants Other pharmaceutical treatment options Treatment guidelines The World


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds